Phase 1 N=76 A Study Assessing the Safety of Oral ATH-399A in Healthy Adult Participants
Healthy Volunteers
Primary: Number of TEAEs — 4; 2; 1; 3 Treatment Emergent Adverse Event
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=102 Impact, Feasibility, and Acceptability of Bladder Basics
Health Knowledge, Attitudes, Practice
Primary: Number and Percentage of Participants Recruited — 429; 183; 70 Participants
N/A N=11 Familial Hyperlipidemia Family Registry
Familial Hyperlipidemia
Primary: Familial Hypercholesterolemia (FH) Determination for Family Members of School Children With Elevated Cholesterol and Documented FH Variant — 3; 8 participants
N/A N=20 Evaluating Mobility Interventions in the Real World
Lower Limb Amputation · Drop Foot
Primary: Minimum Foot Clearance With Different Prostheses — 0.02117; 0.01976; 0.01932; 0.03055 meters
N/A N=300 Evaluation of Wound Infection Rates and Cosmetic Results of Different Suture Materials in Cesarean Skin Incision
Cesarean Section; Infection · Scar
Primary: Evaluation of the Difference Between the Groups in the Number of Patients With Wound Infection at the End of the 10th Postoperative Day — 80; 90; 93; 12 Participants
Phase 4 N=233 Envarsus XR Compared to Immediate Release Tacrolimus
Kidney Transplant Recipients
Primary: Mean Change in Calcineurin Inhibitor-related Symptoms Severity Score — -2.977; -3.139 score on a scale — p=0.944
Phase 3 N=892 A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion)
Macular Edema Secondary to Retinal Vein Occlusion
Primary: Change From Baseline in BCVA Measured by the ETDRS Letter Score at Week 36 — 17.5; 17.4; 18.3 Letters — p=<0.0001
N/A N=50 Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer
Endometrial Cancer · Chemotherapy Effect · Quality of Life
Primary: The Impact in Terms of Overall Quality of Life of Adjuvant Chemotherapy by the QLQ-C30 Questionnaire — 61.7; 71.1 units on a scale
N/A N=2,589 Reactions to Warnings on Hookah Ads
Reactions to Warnings · Hookah Smoking
Primary: Emotional Reactions to Ads — 2.81; 3.46; 3.74; 2.83 score on a scale
Phase 2 N=55 A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease
Celiac Disease · Coeliac Disease
Primary: Changes From Baseline in Villous Height to Crypt Depth (Vh:Cd) as Assessed by Esophagogastroduodenoscopy With Biopsy After 2-week Gluten Challenge (GC) — -0.85; -0.61…
N/A N=69 Retrospective Evaluation of Guided Growth Plate System Plus's Safety and Clinical Performance for the Treatment of Lower Limbs Deformities.
Genu Varum · Genu Valgum · Joint Diseases
Primary: Safety Measurement: Percentage of Subjects Who During the Observation Period Have at Least One Complication Certainly or Potentially Related to the Device in the Studio…
N/A N=48 Pain and Loneliness
Chronic Pain
Primary: Mean Change in Loneliness — -6.6; -2.5 score on a scale
Phase 2 N=64 Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer
Salivary Gland Cancer
Primary: Best Overall Response Rate — 2; 5; 17; 8 Participants
N/A N=25 Can Massage During One Year Improve Health in Health-care Providers Working in Hospital
Massage Therapy · Health-care Workers · Quality of Life
Primary: Symptoms of Stress — 17.4; 13.9 units on a scale — p=0.021
Phase 4 N=3,626 Norepinephrine vs Phenylephrine During General Anesthesia
Anesthesia · Surgery · Hypotension
Primary: Number of Participants With Assigned Vasopressor Given — 1570; 1627 Participants